Product Name: Human CD30 Antibody (Brentuximab, Research Use)
Catalog Number: NBR-0014
Target Name: CD30
Trade Name: Brentuximab
Antibody Drug Description: Brentuximab vedotin (INN; trade name Adcetris) is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL), a type of T cell non-Hodgkin lymphoma. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD30
Synonyms: TNFRSF8; D1S166E
Target Description: Receptor for TNFSF8/CD30L. May play a role in the regulation of cellular growth and transformation of activated lymphoblasts. Regulates gene expression through activation of NF-kappa-B.
Ensembl: ENSG00000120949
Uniprot: P28908